David's cell: 215.704.9418
CAMCEVI® launch campaignAccord BioPharma
CAMCEVI® is the first and only sub-Q leuprolide therapy for advanced prostate cancer that is available in a no-mix, prefilled, ready-to-inject syringe, simplifying GnRH agonist preparation. Check out how we brought this simplified delivery system to life through a memorable visual metaphor.
It conveys the idea as simply as possible.- Urologist, San Bernardino, CA